Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma

Published:2023-07 Issue: Volume:91 Page:129330
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Das Bhaskar C.,Lepe Javier J.^ORCID,Adil Shareef Mohammed,Lomeli Naomi,Das Sasmita,Bota Daniela A.

Funder

National Institutes of Health

National Cancer Institute

National Institute of Neurological Disorders and Stroke

Clinical and Translational Science Institute, Boston University

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. Recent advances in the molecular understanding of glioblastoma;Bleeker;J Neurooncol.,2012

2. Nonsurgical treatment of recurrent glioblastoma;Gallego;Curr Oncol.,2015

3. Radiomic analysis to predict histopathologically confirmed pseudoprogression in glioblastoma patients;McKenney;Adv Radiat Oncol.,2022

4. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016;Ostrom;Neuro Oncol.,2019

5. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment;Van Tellingen;Drug Resist Updat.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP